ETV4 and urogenital neoplasm: The low frequency of rearrangements involving ETV4, ETV5 and FLI1 (less than 2%), and the lack of cell line models harboring rearrangements of these ETS members, resulted in scarce knowledge of their oncogenic roles in prostate carcinogenesis.